Back
HFA Premium Access

Prevalence of sodium glucose co-transporter 2 inhibitor related erythrocytosis (polycythaemia) in real world heart failure patients: a warning for the daily clinical practice

Session: ePosters in chronic heart failure - pharmacotherapy 2
Topic: Pharmacotherapy
Speaker: Mr E. Bruwiere (Nijmegen, NL)
Event: Heart Failure 2023

Congress Presentation

Add to my library

Like

About the speaker

Mr Ewout Bruwiere

Radboud University Medical Centre, Nijmegen (Netherlands (The))
0 follower

6 more presentations in this session

Aspirin and long-Term risk of heart failure in patients with high atherosclerotic risk

Speaker: Associate Professor W. Wongcharoen (Chiang Mai, TH)

Access
Abstract
Slides
Like
Thumbnail

Efficacy and safety of the dual SGLT1 and 2 inhibitor sotagliflozin in combination with a mineralocorticoid receptor antagonist in patients hospitalized for worsening heart failure

Speaker: Doctor M. Davies (The Woodlands, US)

Access
Abstract
Slides
Like
Thumbnail

Utility of a heart failure treatment score (quad score) in predicting early outcomes in patients with heart failure and a reduced ejection fraction

Speaker: Doctor B. Li (Basildon, GB)

Access
Abstract
Slides
Like
Thumbnail

Reverse cardiac remodeling effects of sacubitril/valsartan in adults with congenital heart disease

Speaker: Doctor A. Ferreira (Lisbon, PT)

Access
Abstract
Slides
Like
Thumbnail

Use of trimetazidine in myocardial damage by Covid 19 and LVEF recovery.

Speaker: Doctor R. Rascon Sabido (Veracruz, MX)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

ePosters in chronic heart failure - pharmacotherapy 2

Speakers: Mr E. Bruwiere, Associate Professor W. Wongcharoen, Doctor M. Davies, Doctor B. Li, Doctor A. Ferreira...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources